行情

LCI

LCI

Lannett Co
NYSE

实时行情|Nasdaq Last Sale

9.14
-0.17
-1.83%
盘后: 9.14 0 0.00% 16:00 11/15 EST
开盘
9.43
昨收
9.31
最高
9.43
最低
8.91
成交量
125.81万
成交额
--
52周最高
15.52
52周最低
4.330
市值
3.69亿
市盈率(TTM)
131.70
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

LCI 新闻

  • 软银计划将雅虎日本与Line合并 两公司股价上涨
  • 新浪财经.1小时前
  • 市值最高1.7万亿美元!沙特阿美定价区间公布,全球最大IPO悬念犹存
  • 一财网.2小时前
  • 白宫证实特朗普将访问位于奥斯汀的苹果制造厂
  • 新浪科技.2小时前
  • 即时通讯应用Line与Z Holdings同意在2020年10月合并。
  • 新浪财经.2小时前

更多

所属板块

制药
+1.37%
制药与医学研究
+1.34%

热门股票

名称
价格
涨跌幅

LCI 简况

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June 30, 2016, the Company's products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules. The Company has additional products under development, which are orally administered solid oral-dosage products (tablet/capsule) or oral solutions, nasal, topicals or parentarels, as well as other dosage forms.
展开

Webull提供Lannett Company, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。